{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:49:08Z","timestamp":1792741748421,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T00:00:00Z","timestamp":1595894400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T00:00:00Z","timestamp":1595894400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1245\/s10434-020-08925-5","type":"journal-article","created":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T17:37:23Z","timestamp":1595957843000},"page":"958-967","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Combining Wire Localization of Clipped Nodes with Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Node-Positive Breast Cancer: Preliminary Results from a Prospective Study"],"prefix":"10.1245","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7141-7570","authenticated-orcid":false,"given":"Alejandra","family":"Garc\u00eda-Novoa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3340-4402","authenticated-orcid":false,"given":"Benigno","family":"Acea-Nebril","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlota","family":"D\u00edaz Carballada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Bouz\u00f3n Alejandro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Conde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Cereijo Garea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Ram\u00f3n","family":"Varela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paz","family":"Santiago Freijanes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Antol\u00edn Novoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lourdes","family":"Calvo Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inma","family":"D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Rodr\u00edguez Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquin","family":"Mosquera Oses","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,28]]},"reference":[{"issue":"5","key":"8925_CR1","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1200\/JCO.2007.15.0235","volume":"26","author":"P Rastogi","year":"2008","unstructured":"Rastogi P, Anderson SJ, Bear HD, Geer CE, Kahlenberg MS, Robidoux A et al. Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27. J Clin Oncol. 2008; 26(5):778\u201385. https:\/\/doi.org\/10.1200\/jco.2007.15.0235.","journal-title":"J Clin Oncol."},{"issue":"15","key":"8925_CR2","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1200\/JCO.2011.38.8595","volume":"30","author":"G Von Minckwitz","year":"2012","unstructured":"Von Minckwitz G, Untch M, Blohmer JU, Costa SD, Aidtmann H, Fasching PA, et al. Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes. J Clin Oncol. 2012;30(15):1796\u2013804. https:\/\/doi.org\/10.1200\/jco.2011.38.8595.","journal-title":"J Clin Oncol."},{"issue":"7","key":"8925_CR3","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S1470-2045(13)70166-9","volume":"14","author":"T Kuehn","year":"2013","unstructured":"Kuehn T, Bauerfeind I, Fehm T, Fleige B, Hausschild M, Helms G et al. Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study. Lancet Oncol. 2013; 14(7): 609\u201318.","journal-title":"Lancet Oncol."},{"issue":"3","key":"8925_CR4","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1200\/JCO.2014.55.7827","volume":"33","author":"JF Boileau","year":"2015","unstructured":"Boileau JF, Poirier B, Basik M, Holloway CMB, Gaboury L, Sideris L et al. Sentinel Node Biopsy After neoadjuvant Chemotherapy in Biopsy-Proven Node positive Breast Cancer: the SN FNAC Study. J Clin Oncol. 2015; 33(3): 258\u201364. https:\/\/doi.org\/10.1200\/jco.2014.55.7827","journal-title":"J Clin Oncol."},{"issue":"14","key":"8925_CR5","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1001\/jama.2013.278932","volume":"310","author":"JC Boughey","year":"2013","unstructured":"Boughey JC, Suman VJ, Mittendorf EA, Ahrendt GM, Wilke LG, Taback B et al. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer. The ACOSOG Z1071 (Alliance) Clinical Trial. JAMA. 2013; 310(14): 1455\u201361","journal-title":"JAMA."},{"issue":"10","key":"8925_CR6","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1200\/JCO.2015.64.0094","volume":"34","author":"AS Caudle","year":"2016","unstructured":"Caudle AS, Yang WT, Krishnamurthy S, Mittendorf EA, Black DM, Gilcrease MZ et al. Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissection. J Clin Oncol. 2016;34(10):1072\u20138. https:\/\/doi.org\/10.1200\/jco.2015.64.0094.","journal-title":"J Clin Oncol."},{"issue":"2","key":"8925_CR7","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1097\/SLA.0000000000000558","volume":"261","author":"M Donker","year":"2015","unstructured":"Donker M, Straver ME, Wesseling J, Loo CE, Schot M, Drukker CA et al. Marking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients: the MARI procedure. Ann Surg. 2015;261(2):378\u201382. https:\/\/doi.org\/10.1097\/sla.0000000000000558.","journal-title":"Ann Surg."},{"issue":"3","key":"8925_CR8","doi-asserted-by":"publisher","first-page":"646","DOI":"10.2214\/AJR.07.2460","volume":"191","author":"DG Bedi","year":"2008","unstructured":"Bedi DG, Krishnamurthy R, Krishnamurthy S, Edeiken BS, Le-Petross H, Fornage BD et al. Cortical morphologic features of axillary lymph nodes as a predictor of metastasis in breast cancer: in vitro sonographic study. AJR Am J Roentgenol. 2008;191(3):646\u201352. https:\/\/doi.org\/10.2214\/ajr.07.2460.","journal-title":"AJR Am J Roentgenol."},{"key":"8925_CR9","unstructured":"NCCN Clinical Practice Guidelines in Oncology. Version 2.2019. National Comprehensive Cancer Network. Consultado por \u00faltima vez: marzo 2020. Available at: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/breast_blocks.pdf."},{"issue":"8","key":"8925_CR10","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1093\/annonc\/mdz189","volume":"30","author":"F Cardoso","year":"2019","unstructured":"Cardoso F, Kyriakides S, Ohno S, Penault-Llorca F, Poortmans P, Rubio IT et al. Early breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2019;30(8):1194\u2013220. https:\/\/doi.org\/10.1093\/annonc\/mdz189.","journal-title":"Ann Oncol."},{"issue":"8","key":"8925_CR11","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1002\/bjs.7073","volume":"97","author":"ME Straver","year":"2010","unstructured":"Straver ME, Loo CE, Alderliesten T, Rutgers EJ, Vrancken Peeters MT. Marking the axilla with radioactive iodine seeds (MARI procedure) may reduce the need for axillary dissection after neoadjuvant chemotherapy for breast cancer. Br J Surg. 2010;97(8):1226\u201331. https:\/\/doi.org\/10.1002\/bjs.7073.","journal-title":"Br J Surg."},{"issue":"2","key":"8925_CR12","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1001\/jamasurg.2014.1086","volume":"150","author":"AS Caudle","year":"2015","unstructured":"Caudle AS, Yang WT, Mittendorf EA, Black DM, Hwang R, Hobbs B et al. Selective surgical localization of axillary lymph nodes containing metastases in patients with breast cancer: a prospective feasibility trial. JAMA Surg. 2015;150(2):137\u201343. https:\/\/doi.org\/10.1001\/jamasurg.2014.1086","journal-title":"JAMA Surg."},{"issue":"3","key":"8925_CR13","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1245\/s10434-017-6270-z","volume":"25","author":"C Siso","year":"2018","unstructured":"Siso C, de Torres J, Esqueva-Colmenarejo A, Espinosa-Bravo M, Rus N, Cordoba O et al. Intraoperative ultrasound-guided excision of axillary clip in patients with node-positive breast cancer treated with neoadjuvant therapy (ILINA trial): a new tool to guide the excision of the clipped node after neoadjuvant treatment. Ann Surg Oncol. 2018;25(3):784\u2013791. https:\/\/doi.org\/10.1245\/s10434-017-6270-z.","journal-title":"Ann Surg Oncol."},{"issue":"4","key":"8925_CR14","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1097\/SLA.0000000000001375","volume":"263","author":"JC Boughey","year":"2016","unstructured":"Boughey JC, Ballman KV, Le-Petross HT, McCall LM, Mittendorf EA, Ahrendt GM et al. Identification and resection of clipped node decreases the false-negative rate of sentinel lymph node surgery in patients presenting with node-positive breast cancer (T0-T4, N1-N2) who receive neoadjuvant chemotherapy: results from ACOSOG Z1071 (Alliance). Ann Surg. 2016;263(4):802\u20137. https:\/\/doi.org\/10.1097\/sla.0000000000001375","journal-title":"Ann Surg."},{"issue":"3","key":"8925_CR15","doi-asserted-by":"publisher","first-page":"801","DOI":"10.4143\/crt.2017.210","volume":"50","author":"S Park","year":"2018","unstructured":"Park S, Koo JS, Kim GM, Sohn J, Kim SI, Cho YU et al. Feasibility of charcoal tattooing of cytology-proven metastatic axillary lymph node at diagnosis and sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer patients. Cancer Res Treat. 2018;50(3):801\u201312","journal-title":"Cancer Res Treat."},{"issue":"13","key":"8925_CR16","doi-asserted-by":"publisher","first-page":"4241","DOI":"10.1245\/s10434-015-4527-y","volume":"22","author":"D Plecha","year":"2015","unstructured":"Plecha D, Bai S, Patterson H, Thompson C and Shenk R. Improving the accuracy of axillary lymph node surgery in breast cancer with ultrasound-guided wire localization of biopsy proven metastatic lymph nodes. Ann Surg Oncol. 2015;22(13):4241-6. https:\/\/doi.org\/10.1245\/s10434-015-4527-y.","journal-title":"Ann Surg Oncol."},{"issue":"9","key":"8925_CR17","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1016\/j.ejso.2018.05.035","volume":"44","author":"S Hartmann","year":"2018","unstructured":"Hartmann S, Reimer T, Gerber B, Stubert J, Stengel B, Stachs A et al. Wire localization of clip-marked axillary lymph nodes in breast cancer patients treated with primary systemic therapy. Eur J Surg Oncol. 2018; 44(9):1307\u20131311. https:\/\/doi.org\/10.1016\/j.ejso.2018.05.035.","journal-title":"Eur J Surg Oncol."},{"issue":"3","key":"8925_CR18","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1097\/SLA.0000000000003075","volume":"269","author":"JM Simons","year":"2019","unstructured":"Simons JM, van Nijnatten TJA, van der Pol CC, Luiten EJT, Koppert LB, Smidt ML. Diagnostic\u00a0accuracy\u00a0of different surgical procedures for axillary staging after neoadjuvant systemic therapy in node-positive breast cancer: a systematic review and meta-analysis. Ann Surg. 2019;269(3):432\u201342.","journal-title":"Ann Surg."},{"key":"8925_CR19","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1245\/s10434-014-4034-6","volume":"22","author":"N Choy","year":"2015","unstructured":"Choy N, Lipson J, Porter C, Ozawa M, Kieryn A, Pal S et al. Initial results with preoperative tattooing of biopsied axillary lymph nodes and correlation to sentinel lymph nodes in breast. Cancer patients. Ann Surg Oncol. 2015;22:377\u201382. https:\/\/doi.org\/10.1245\/s10434-014-4034-6.","journal-title":"Ann Surg Oncol."},{"issue":"10","key":"8925_CR20","doi-asserted-by":"publisher","first-page":"3030","DOI":"10.1245\/s10434-018-6575-6","volume":"25","author":"N Cabioglu","year":"2018","unstructured":"Cabioglu N, Karanlik H, Kangal D, \u00d6zkurt E, \u00d6ner G, Sezen F et al. Improved false-negative rates with intraoperative identification of clipped nodes in patients undergoing sentinel lymph node biopsy after neoadjuvant chemotherapy. Ann Surg Oncol. 2018;25(10):3030\u20136. https:\/\/doi.org\/10.1245\/s10434-018-6575-6.","journal-title":"Ann Surg Oncol."},{"key":"8925_CR21","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1245\/s10434-019-07419-3","volume":"26","author":"R Patel","year":"2019","unstructured":"Patel R, MacKerricher W, Tsai J, Choy N, Lipson J, Ikeda D et al. pretreatment tattoo marking of suspicious axillary lymph nodes: reliability and correlation with sentinel lymph node. Ann Surg. Oncol. 2019;26:2452\u20138. https:\/\/doi.org\/10.1245\/s10434-019-07419-3.","journal-title":"Ann Surg Oncol."},{"issue":"3","key":"8925_CR22","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.clbc.2019.01.013","volume":"19","author":"I Natsiopoulos","year":"2019","unstructured":"Natsiopoulos I, Intzes S, Liappis T, Zarampoukas K, Zarampoukas T, Zacharopoulou V, Papazisis K, et al. Axillary lymph node tattooing and targeted axillary dissection in breast cancer patients who presented as cN+\u2009before neoadjuvant chemotherapy and became cN0 after treatment. Clin Breast Cancer. 2019;19(3):208\u201315. https:\/\/doi.org\/10.1016\/j.clbc.2019.01.013.","journal-title":"Clin Breast Cancer."},{"issue":"12","key":"8925_CR23","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1002\/bjs.11320","volume":"106","author":"JM Simons","year":"2019","unstructured":"Simons JM, van Pelt MLMA, Marinelli AWKS, Straver ME, Zeillemaker AM, Pereira Arias-Bouda LM et al. Excision of both pretreatment marked positive nodes and sentinel nodes improves axillary staging after neoadjuvant systemic therapy in breast cancer. Br J Surg. 2019;106(12):1632\u20139. https:\/\/doi.org\/10.1002\/bjs.11320.","journal-title":"Br J Surg."},{"issue":"2","key":"8925_CR24","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/bcr281","volume":"3","author":"PJ Tanis","year":"2001","unstructured":"Tanis PJ, Nieweg OE, Vald\u00e9s Olmos RA, Th Rutgers EJ, Kroon BB. History of sentinel node and validation of the technique. Breast Cancer Res. 2001;3(2):109\u201312.","journal-title":"Breast Cancer Res."},{"issue":"12","key":"8925_CR25","doi-asserted-by":"publisher","first-page":"3794","DOI":"10.1245\/s10434-019-07733-w","volume":"26","author":"JC Boughey","year":"2019","unstructured":"Boughey JC. Identifying residual nodal disease in sentinel lymph node surgery after neoadjuvant chemotherapy for breast cancer. Ann Surg Oncol. 2019;26(12):3794\u20137. https:\/\/doi.org\/10.1245\/s10434-019-07733-w.","journal-title":"Ann Surg Oncol."},{"issue":"3","key":"8925_CR26","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1097\/SLA.0000000000003126","volume":"271","author":"S Samiei","year":"2020","unstructured":"Samiei S, van Nijnatten TJA, Munck L, Keymeulen KBMI, Simons JM, Kooreman LFS et al. Correlation between pathologic complete response in the breast and absence of axillary lymph node metastases after neoadjuvant systemic therapy. Ann Surg. 2020;271(3):574\u201380","journal-title":"Ann Surg."},{"issue":"4","key":"8925_CR27","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1097\/SLA.0000000000002953","volume":"268","author":"OM Fayanju","year":"2018","unstructured":"Fayanju OM, Ren Y, Thomas SM, Greenup RA, Plichta JK, Rosenberger LH et al. The clinical significance of breast-only and node-only pathologic complete response (pCR) after neoadjuvant chemotherapy (NACT): a review of 20,000 breast cancer patients in the national cancer data base (NCDB). Ann Surg. 2018;268(4):591\u2013601","journal-title":"Ann Surg."},{"issue":"3","key":"8925_CR28","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/SLA.0b013e3181f08f32","volume":"252","author":"AE Giuliano","year":"2010","unstructured":"Giuliano AE, McCall L, Beitsch P, Whitworth PW, Blumencranz P, Laitch AM et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 Randomized Trial. Ann Surg. 2010; 252(3): 426\u201333.","journal-title":"Ann Surg."},{"issue":"3","key":"8925_CR29","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/SLA.0000000000001863","volume":"264","author":"AE Giuliano","year":"2016","unstructured":"Giuliano AE, Ballman K, McCall L, Beitsch P, Whitworth PW, Blumencranz P et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: long-term follow-up from the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 randomized trial. Ann Surg. 2016; 264(3): 413\u201320. https:\/\/doi.org\/10.1097\/sla.0000000000001863.","journal-title":"Ann Surg."},{"key":"8925_CR30","doi-asserted-by":"publisher","unstructured":"Galimberti V, Cole BF, Zurrida S, Viale G, Luini A, Veronesi P et al; International Breast Cancer Study Group Trial 23-01 investigators. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomized controlled trial. Lancet Oncol. 2013;14(4):297\u2013305. https:\/\/doi.org\/10.1016\/s1470-2045(13)70035-4.","DOI":"10.1016\/s1470-2045(13)70035-4"},{"issue":"10","key":"8925_CR31","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/S1470-2045(18)30380-2","volume":"19","author":"V Galimberti","year":"2018","unstructured":"Galimberti V, Cole BF, Viale G, Veronesi P, Vivini E, Intra M et al. Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial. Lancet Oncol. 2018;19(10):1385\u201393. https:\/\/doi.org\/10.1016\/s1470-2045(18)30380-2.","journal-title":"Lancet Oncol."},{"issue":"1","key":"8925_CR32","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1245\/s10434-012-2569-y","volume":"20","author":"M Sol\u00e1","year":"2013","unstructured":"Sol\u00e1 M, Alberro JA, Fraile M, Santesteban P, Ramos M, Fabregas R et al. Complete axillary lymph node dissection versus clinical follow-up in breast cancer patients with sentinel node micrometastasis: final results from the multicenter clinical trial AATRM 048\/13\/2000. Ann Surg Oncol. 2013;20(1):120\u20137. https:\/\/doi.org\/10.1245\/s10434-012-2569-y.","journal-title":"Ann Surg Oncol."},{"key":"8925_CR33","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","volume":"15","author":"M Donker","year":"2014","unstructured":"Donker M, van Tienhoven G, Straver ME, Meijnen P, van de Velde CJ, Mansel RE et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol. 2014;15:1303\u201310.","journal-title":"Lancet Oncol."},{"issue":"9","key":"8925_CR34","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.ejso.2016.06.088","volume":"42","author":"A S\u00e1volt","year":"2016","unstructured":"S\u00e1volt A, M\u00e1trai Z, Polg\u00e1r C, Udvarhelyi N, Kov\u00e1cs E, Gy\u00d3rffy B et al. Optimal treatment of the axilla after positive sentinel lymph node biopsy in primary invasive breast cancer: OTOASOR Trial, a randomized, single centre, phase III, non-inferiority trial. Eur J Surg Oncol. 2016;42(9):100.","journal-title":"Eur J Surg Oncol."},{"key":"8925_CR35","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/0140-6736(92)91591-U","volume":"339","author":"PA Cabanes","year":"1992","unstructured":"Cabanes PA, Salmon RJ, Vilcoq JR, Durand JC, Fourquet A, Gautier C et al. Value of axillary dissection in addiction to lumpectomy and radiotherapy in early breast cancer. Lancet. 1992; 339: 1245\u20138","journal-title":"Lancet."},{"issue":"1","key":"8925_CR36","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1200\/JCO.2004.12.108","volume":"22","author":"C Louis-Sylvestre","year":"2004","unstructured":"Louis-Sylvestre C, Clough K, Asselain B, Vilcoq JR, Salmon RJ, Campana F et al. Axillary treatment in conservative management of operable breast cancer: dissection or radiotherapy? Results of a randomized study with 15\u00a0years of follow-up. J Clin Oncol. 2004;22(1):97\u2013101.","journal-title":"J Clin Oncol."},{"issue":"1","key":"8925_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/01.sla.0000167759.15670.14","volume":"242","author":"G Martelli","year":"2005","unstructured":"Martelli G, Boracchi P, De Palo M, Pilotti S, Oriana S, Zucali R et al. A randomized trial comparing axillary dissection to no axillary dissection in older patients with T1N0 breast cancer: results after 5\u00a0years of follow-up. Ann Surg. 2005;242(1):1-9","journal-title":"Ann Surg."},{"issue":"3","key":"8925_CR38","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1200\/JCO.2005.01.5784","volume":"24","author":"CM Rudenstam","year":"2006","unstructured":"International Breast Cancer Study Group, Rudenstam CM, Zahrjeh D, Forbes JF, Crivellari D, Holmberg SB, Rey P et al. Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10\u201393. J Clin Oncol. 2006;24(3):337\u201344.","journal-title":"J Clin Oncol."},{"issue":"11","key":"8925_CR39","doi-asserted-by":"publisher","first-page":"3502","DOI":"10.1245\/s10434-019-07517-2","volume":"26","author":"SM Wong","year":"2019","unstructured":"Wong SM, Almana N, Choi J, Hu J, Gagnon H, Natsuhara K et al. Prognostic significance of residual axillary nodal micrometastases and isolated tumor cells after neoadjuvant chemotherapy for breast cancer. Ann Surg Oncol. 2019;26(11):3502\u20139. https:\/\/doi.org\/10.1245\/s10434-019-07517-2.","journal-title":"Ann Surg Oncol."},{"issue":"4","key":"8925_CR40","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1002\/cncr.10741","volume":"95","author":"ER Fisher","year":"2002","unstructured":"Fisher ER. Pathobiology of preoperative chemotherapy: findings from de National Surgical Adjuvant Breast and Bowel (NSABP) protocol B-18. Cancer. 2002;95(4):681\u201395","journal-title":"Cancer."},{"issue":"1","key":"8925_CR41","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s10549-017-4157-0","volume":"163","author":"TJA van Nijnatten","year":"2017","unstructured":"van\u00a0Nijnatten TJA, Simons JM, Moossdorff M, de\u00a0Munck L, Lobbes MBI, van der\u00a0Pol CC et al. Prognosis of residual axillary disease after neoadjuvant chemotherapy in clinically node-positive breast cancer patients: isolated tumor cells and micrometastases carry a better prognosis than macrometastases. Breast Cancer Res Treat. 2017; 163(1):159\u201366. https:\/\/doi.org\/10.1007\/s10549-017-4157-0.","journal-title":"Breast Cancer Res Treat."},{"key":"8925_CR42","unstructured":"Corrado Tinterri. Breast Cancer: Axillary Conservation After Neoadjuvant Chemotherapy in Micro Metastatic Sentinel Lymph Nodes. (NEONOD2). Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04019678. Accessed August 2019"},{"key":"8925_CR43","unstructured":"Boughey J. Comparison of Axillary Lymph Node Dissection with Axillary Radiation for Patients with Node-Positive Breast Cancer Treated with Chemotherapy. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01901094. Accessed August 2019"},{"key":"8925_CR44","unstructured":"Ana Car Peterko. SLNB After Neoadjuvant Treatment in Node Positive Patients. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03833960. Accessed August 2019"},{"issue":"5","key":"8925_CR45","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.clbc.2017.04.006","volume":"17","author":"TJA Van Nijnatten","year":"2017","unstructured":"Van Nijnatten TJA, Simons JM, Smidt ML, van der Pol CC, van Diest PJ, Jager A et al. A novel less-invasive approach for axillary staging after neoadjuvant chemotherapy in patients with axillary node-positive breast cancer by combining radioactive iodine seed localization in the axilla with the sentinel node procedure (RISAS): a Dutch Prospective Multicenter Validation Study. Clin Breast Cancer. 2017;17(5):399\u2013402. https:\/\/doi.org\/10.1016\/j.clbc.2017.04.006.","journal-title":"Clin Breast Cancer."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-020-08925-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-020-08925-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-020-08925-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T23:28:56Z","timestamp":1627428536000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-020-08925-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,28]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["8925"],"URL":"https:\/\/doi.org\/10.1245\/s10434-020-08925-5","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,28]]},"assertion":[{"value":"1 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Alejandra Garc\u00eda-Novoa, Benigno Acea-Nebril, Carlota D\u00edaz Carballada, Alberto Bouz\u00f3n Alejandro, Carmen Conde, Carmen Cereijo Garea, Jos\u00e9 Ram\u00f3n Varela, Paz Santiago Freijanes, Silvia Antol\u00edn Novoa, Lourdes Calvo Mart\u00ednez, Inma D\u00edaz, Sofia Rodr\u00edguez Mart\u00ednez, and Joaquin Mosquera Oses have no disclosures or financial support to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}